Abstract |
This study was designed to check whether insulin supplementation is crucial for inducing diabetic nephropathy (DNP) in Wistar rats. Diabetes was induced by a single intraperitoneal injection of streptozotocin. The urinary biochemical parameters such as albumin, creatinine and urea nitrogen were monitored every two weeks. The histological changes in the kidney were observed at the end of both fifth and seventh month. Immunohistochemical analyses of VEGF, ERK-1 and NF-kappaB expression were performed to demonstrate mesangial expansion and glomerulosclerosis, which are the defining histological features of nephropathy. A significant change in the urinary biochemistry was observed in diabetic animals at the end of four months, but the aforementioned quantitative changes were delayed in diabetic animals treated with insulin. At the end of seven months, the diabetic animals showed prominent histological changes such as glomerular basement membrane thickening, nodular glomerulosclerosis and mesangial expansion. However, these changes were not observed in diabetic animals treated with insulin even at the end of the study. From the results, it can be concluded that there is no need of insulin supplementation for inducing DNP, when the animals are induced with an optimal dose of 45 mg/kg body weight of streptozotocin.
|
Authors | Shiju Thomas Michael, Rajesh Nachiappa Ganesh, Pragasam Viswanathan |
Journal | Indian journal of experimental biology
(Indian J Exp Biol)
Vol. 50
Issue 12
Pg. 867-74
(Dec 2012)
ISSN: 0019-5189 [Print] India |
PMID | 23986970
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Blood Glucose
- Insulin, Long-Acting
- NF-kappa B
- Vascular Endothelial Growth Factor A
- vascular endothelial growth factor A, rat
- Streptozocin
- Creatinine
- Mitogen-Activated Protein Kinase 3
|
Topics |
- Albuminuria
(chemically induced, pathology)
- Animals
- Blood Glucose
(analysis)
- Creatinine
(urine)
- Diabetes Mellitus, Experimental
(complications, drug therapy)
- Diabetic Nephropathies
(chemically induced, pathology, urine)
- Disease Progression
- Dose-Response Relationship, Drug
- Insulin, Long-Acting
(administration & dosage, pharmacology, therapeutic use)
- Kidney
(drug effects, pathology)
- Male
- Mitogen-Activated Protein Kinase 3
(metabolism)
- NF-kappa B
(metabolism)
- Rats
- Rats, Wistar
- Streptozocin
(administration & dosage, toxicity)
- Time Factors
- Vascular Endothelial Growth Factor A
(metabolism)
|